DTE vs ZVRA
DTE (DTE) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
DTE does not have a complete income-statement cache yet.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
DTE currently screens at market cap $0. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the DTE and ZVRA stock pages for the full models.
Not investment advice.